European Archives - Page 843 of 1616 - European Medical Journal

Empowering Women Through Menopausal Awareness

While awareness of the issues facing women leading up to, during, and following the menopause has increased in recent years…

Redefining Renal Cell Carcinoma

Renal cell carcinoma (RCC) is the most common primary tumour originating from the kidney, and accounts for more than 90% of all renal…

Liraglutide for Obesity in Type 2 Diabetes

Obesity is a major risk factor for the development of Type 2 diabetes (T2D), with the prevalence of both increasing in a parallel manner…

Autologous Transplant or Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Large B-cell Lymphoma: How to Choose?

Expert Madiha Iqbal, Consultant and Assistant Professor of Medicine, Mayo Clinic, Jacksonville, Florida, USA, presents on the treatment…

How to Translate Science into Patient Care: Long Term Outcomes in Clinical Trials

Watch our latest webinar on-demand now, exploring the ways in which clinical decision making is affected by long term outcomes in…

Dermatology Meets Obstetrics: A Psoriasis Step Forward Together with UCB

UCB hosted an industry expert hub session entitled ‘Dermatology and Obstetrics: How Can Teamwork Lead to Compatible Treatment Choices…

Active Monitoring Elevates Long-Term Cervical Cancer Risk

Researchers have found that females undergoing active surveillance for cervical intraepithelial neoplasia Grade 2 face an elevated long-term risk of cervical cancer, compared to those opting for immediate treatment.

The Dawn of a New Era in Vitiligo Management

This video explores, understanding vitiligo as an autoimmune skin disease, integrating ruxolitinib cream into vitiligo treatment strategy, and the importance of real-world evidence in reinforcing findings from clinical trials.

3D-Printed Trainer for Ultrasound-Guided Line Placement

Ultrasonography (US, also known as sonographic imaging, ultrasound) is an important medical imaging technique that uses high-frequency…

Has medical affairs reached 'strategic pillar' standing?

The value of medical affairs is not up for debate, but are companies allocating enough time and resources to make it the strategic function it can be?